FDA User Fee Programs: Advancing Cures, Helping Patients
10:00am ET - 11:15am ET
The Food and Drug Administration (FDA) is tasked with regulating new drugs, devices, and diagnostics, and implementing regulatory policies that govern biomedical innovation in the United States. User fee programs have been created to supplement FDA's funding and enable the agency to bring innovative products to patients faster and meet the challenges of 21st Century medicine. This briefing will explore how the user fee programs work, the resources they provide to the FDA, the role of the biomedical industry, and the impact on patient care. Participants will also learn about the reauthorization cycles and funding issues. This multi-state briefing will include experts from the following life sciences communities: CLSA, BIO, AdvaMed, FDA, Philips Healthcare, and National Health Council.
Contact: Jenny Carey
Contact Email: firstname.lastname@example.org
121 Cannon House Office Building